|
|
|
|
Back to
Financial results |
|
| ARVIND REMEDIES
LIMITED |
|
| AUDITED
FINANCIAL RESULTS FOR THE QUARTER ENDED 30-06-2009 |
|
| |
|
|
(Rupees in Lakhs) |
|
|
| Particulars |
Nine
Month Ended |
<----Quarter
Ended-------> |
<---For the
year ended--> |
|
| |
31.12.2008 |
30.06.2009 |
30.06.2008 |
31.03.2009 |
|
| |
|
(Audited) |
(Audited) |
(Audited) |
|
| Net Income
from Sales |
######## |
6,632.98
|
5,103.45 |
21788.84 |
|
| Other
Operating Income |
2.09 |
0.47 |
0.47 |
3.23 |
|
| TOTAL
INCOME |
15898.64 |
6633.45 |
5103.92 |
21792.07 |
|
| Expenditure |
|
|
|
|
|
| a)
(Increase)/Decrease in stock |
50.16 |
(114.53) |
(176.58) |
(14.73) |
|
| b) Consumption of Materials |
######## |
5,618.97 |
4,472.62 |
18,728.07 |
|
| c) Power & Fuel |
106.18 |
10.19 |
7.01 |
42.42 |
|
| d) Depreciation |
323.74 |
52.94 |
48.01 |
193.60 |
|
| e) Employee Cost |
323.74 |
130.57 |
103.65 |
492.91 |
|
| f) Other expenditure |
227.94 |
170.10 |
139.15
|
564.91 |
|
| Total (a)
to (e) |
14563.09 |
5868.24 |
4593.86 |
20007.18 |
|
| Profit
from Operations before other Income and Interest |
1335.55 |
765.21 |
510.06 |
1784.89 |
|
| Other
Income |
100.25 |
4.91 |
2.82 |
80.20 |
|
| Profit
before Interest and Exceptional |
126.85 |
770.12 |
512.88 |
1,865.09 |
|
| Interest |
147.47 |
294.24 |
198.46 |
1147.99 |
|
| Profit
after Interest but before Execeptional Items |
960.98 |
475.88 |
314.42 |
717.10 |
|
| Execptional
Items |
|
- |
- |
- |
|
| Profit
from Ordinary activities Before
Tax(12+13) |
#REF! |
475.88 |
314.42 |
717.10 |
|
| Tax
Expenses |
|
|
|
|
|
| Current Tax |
90.00 |
105.00 |
30.00 |
102.80 |
|
| Deferred Tax |
7.70 |
(13.87) |
(8.67) |
132.67 |
|
| Net Profit
from Ordinary activities after Tax(14-15) |
#REF! |
384.75 |
293.09 |
481.63 |
|
| Extraordinary
Items (net of tax expense) |
-
|
- |
- |
- |
|
| Net Profit
for the Period |
#REF! |
384.75 |
293.09 |
481.63 |
|
| Paid-up
EquityShareCapital ( FaceValueRe.1 / share) |
2,600.50 |
2,600.50 |
2,600.50 |
2600.50 |
|
| Reserves
excluding Revaluation Reserve |
|
|
- |
2211.37 |
|
| Earnigs per Share(EPS): Basic
and Diluted EPS before and after extraordinary Items - (Rs.) |
#REF! |
0.15 |
0.11 |
0.19 |
|
| Public Shareholding |
|
|
|
|
|
| Number of shares |
1.94E+08 |
194205340 |
194205340 |
194205340 |
|
| Percentage of Shareholding |
74.68% |
74.68% |
74.68% |
74.68% |
|
| Promoters
and Promoter Group shareholding - |
|
|
|
|
|
| a) Pledged / encumbered |
|
|
|
|
|
| - No of Shares |
Nil |
Nil |
|
Nil |
|
| - Percentage of shares(as % of
total |
-- |
-- |
|
-- |
|
| shareholding of promoters and
promoter group) |
|
|
|
|
|
| - Percentage of shares(as % of
total capital) |
-- |
-- |
|
-- |
|
| a) Non-encumbered |
|
|
|
|
|
| - No of Shares |
|
65844660 |
|
65844660 |
|
| - Percentage of shares(as % of
total |
|
100.00% |
|
100.00% |
|
| shareholding of promoters and
promoter group) |
|
|
|
|
|
| - Percentage of shares(as % of
total capital) |
|
25.32% |
|
25.32% |
|
| |
|
|
|
|
|
| The above results were reviewed by the audit committee and taken on record at the meeting of the Board
of |
|
| Directors held on
July 31, 2009 |
|
| The Company operates only in one buriness segment namely
formulations. |
|
| Provision for Income Tax has been made on estimated Taxable
Profit for the year. |
|
| Previous period's figures have been regrouped / rearranged wherever necessary to confirm to the
current |
|
| period's classification. |
|
| During the quarter, 35 Investor Compliants were received and
disposed of. There were no Investor
Compliants pending for the redressal as at the commencement and end of the
quarter. |
|
| pending for the redressal as at the commencement and end of the
quarter. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chennai - 600 084 |
|
|
For ARVIND
REMEDIES LTD |
| Date: |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
DR.B.Arvind Shah |
|
| |
|
|
CEO & Managing Director |
|
|
|
|
|
|
|
|
|
|
|
|
Back to
Financial results |
|
|
|
|
|
|